QuintilesIMS Real-World Insights Bibliography

Type 2 diabetes, high blood pressure and acute pancreatitis
Author(s): Bexelius TS, Ljung R, Garcia Rodriguez LA
Affiliations(s): Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, and Department of Medical Epidemiology and Biostatistics, Karolinska Institute
Publication(s): 
Document Type(s): Article
Countries: UK
C:
Y:
Cardiovascular disease, Diabetes, Miscellaneous
2016
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
Determinants of Glycemic Response to Add-On Therapy with a Dipeptidyl Peptidase-4 Inhibitor: A Retrospective Cohort Study Using a United Kingdom Primary Care Database
Author(s): Mamza J, Mehta R, Donnelly R, Idris I
Affiliations(s): Division of Medical Sciences & Graduate Entry Medicine, School of Medicine; Trent Research Design Services, University of Nottingham
Publication(s): 
Document Type(s): Article
Countries: UK
C:
Y:
Diabetes
2016
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study
Author(s): Mamza J, Mehta R, Donnelly R, Idris I
Affiliations(s): Division of Medical Sciences & Graduate Entry Medicine , University of Nottingham; Research Design Services (East Midlands), School of Medicine
Publication(s): 
Document Type(s): Article
Countries: UK
C:
Y:
Diabetes
2016
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
Intra-cluster and inter-period correlation coefficients for cross-sectional cluster randomised controlled trials for type-2 diabetes in UK primary care
Author(s): Martin J, Girling A, Nirantharakumar K, Ryan R, Marshall T, Hemming K
Affiliations(s): Institute of Applied Health Research, University of Birmingham
Publication(s): 
Document Type(s): Article
Countries: UK
C:
Y:
Diabetes
2016
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
Risk factors for diabetic retinopathy in people with Type 2 diabetes: A case-control study in a UK primary care setting
Author(s): Martín-Merino E, Fortuny J, Rivero-Ferrer E, Lind M, Garcia-Rodriguez LA
Affiliations(s): Centro Español de Investigación Farmacoepidemiológica; DS&E –GlobalClinicalEpidemiology,NovartisFarmaceuticaS.A.,Barcelona; Institute ofMedicine,UniversityofGothenburg,Gothenburg; Department ofMedicine,NU-HospitalOrganization,Uddevalla
Publication(s): 
Document Type(s): Article
Countries: UK
C:
Y:
Diabetes
2016
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
Identifying Cases of Type 2 Diabetes in Heterogeneous Data Sources: Strategy from the EMIF Project
Author(s): Roberto G, Leal I, Sattar N, Loomis AK, Avillach P, Egger P, van Wijngaarden R, Ansell D, Reisberg S, Tammesoo ML, Alavere H, Pasqua A, Pedersen L, Cunningham J, Tramontan L, Mayer MA, Herings R, Coloma P, Lapi F, Sturkenboom M, van der Lei J, Schuemie MJ, Rijnbeek P, Gini R
Affiliations(s): Development, Groton, Connecticut, United States of America; Department of Biomedical Informatics, Harvard Medical School & Children’s Hospital Informatics Program, Boston Children’s Hospital, Boston, Massachusetts, United States of America; GlaxoSmithKline, Worldwide Epidemiology GSK, Stockley Park West, Uxbridge, United Kingdom,; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands; The Health Improvement Network, Cegedim Strategic Data Medical Research Ltd, London, United Kingdom; Quretec, Software Technology and Applications Competence Center, University of Tartu, Tartu, Estonia; Estonian Genome Center, University of Tartu, Tartu, Estonia; Tartu University Hospital, Tartu, Estonia; Health Search, Italian College of General Practitioners and Primary Care, Firenze, Italy; Department of Clinical Epidemiology, Aarhus University Hosptial, Aarhus, Denmark; University of Manchester, Manchester, United Kingdom; Arsenàl.IT Consortium, Veneto's Research Centre for eHealth Innovation, Treviso, Italy,; Hospital del Mar Medical Research Institute (IMIM) and Universitat Pompeu Fabra, Barcelona, Spain; Janssen Research & Development, Epidemiology, Titusville, New Jersey, United States of America,; Observational Health Data Sciences and Informatics, New York, New York, United States of America
Publication(s): 
Document Type(s): Article
Countries: UK
C:
Y:
Diabetes
2016
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study
Author(s): Sharma M, Nazareth I, Petersen I
Affiliations(s): Department of Primary Care and Population Health, University College London; Department of Clinical Epidemiology, Aarhus University
Publication(s): 
Document Type(s): Article
Countries: UK
C:
Y:
Diabetes
2016
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies.
Author(s): McDonell AL1, Kiiskinen U2, Zammit DC3, Kotchie RW1, Thuresson PO3, Nicolay C4, Haslam T1, Bruinsma M5, Janszen-Van Oosterhout AJ6, Otto T4
Affiliations(s): 1IMS Health, London, UK; 2Eli Lilly and Company, Helsinki, Finland; 3IMS Health, Basel, Switzerland; 4Eli Lilly and Company, Bad Homburg, Germany; 5IMS Health, Rotterdam, the Netherlands; 6Eli Lilly Nederland, Houten, the Netherlands
Publication(s): ClinicoEconomics and Outcomes Research, 2015; 7:95-103
Document Type(s): Article
Countries: Germany, Netherlands, UK
Click here for the abstract
C:
Y:
Diabetes
2015
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
Cost-effectiveness of switching from biphasic human insulin (BHI) to biphasic insulin aspart 30 (BIAsp-30) in type 2 diabetes patients with suboptimal glycaemic control in Singapore
Author(s): Goh SY1, Tan SC2, Lim LC3, Chua B4, Hunt B5
Affiliations(s): 1 Department of Endocrinology, Singapore General Hospital, Singapore 2 Health Economics & Outcomes Research, IMS Health Asia Pacific, Singapore 3 Department of Medicine, Alexandra Hospital, Singapore 4 Department of Vascular Surgery, Singapore General Hospital, Singapore 5 Ossian Health Economics and Communications, Switzerland
Publication(s): Journal of Diabetology, February 2015; 1:2
Document Type(s): Online article
Countries: Singapore
C:
Y:
Diabetes
2015
  L:
A:
English
Cost effectiveness
  Add to report
 
 
If we followed NICE guidelines and treated people with diabetes earlier, patients and the NHS would benefit from a reduction in complications, mortality and direct healthcare costs
Author(s): Baxter M1, Hex N2, Samyshkin Y3, Hudson R1, Mahon J2, Alexiou D3, Bartlett C2
Affiliations(s): 1 Sanofi, Guildford, UK, 2 York Health Economics Consortium, York, UK, 3 IMS Health, London, UK
Publication(s): Diabetes UK Professional Conference 2015 11-13 March 2015, ExCeL London
Document Type(s): Poster
Countries: UK
C:
Y:
Diabetes
2015
  L:
A:
English
Cost analysis
  Add to report
 
 
First Page Previous Page  2 of 47 Next Page Last Page